The Lancet Refuses Senate Request on COVID-19 Origins Inquiry
The Lancet refused a U.S. Senate request for evidence on COVID-19 origins. Purdue Pharma's sentencing was delayed, while insurers moved to reduce prior-authorization paperwork.
CVS Health
CompanyAlso known as: CVS Health
Company Profile
CVS Health is a leading health solutions company that serves consumers through retail pharmacy, walk-in and primary care clinics, pharmacy benefit management, and insurance services. The company says it is building a more connected, compassionate, and accessible health care experience.
- Website
- https://www.cvshealth.com
- Headquarters
- Woonsocket, Rhode Island, USA
- Founded
- 1963
- Stock Ticker
- NYSE:CVS
Related News
Retail pharmacy chains pull back from clinical trials after post-COVID expansion
Retail pharmacy chains that expanded into clinical trials after COVID have since slowed or pulled back. CVS said it would exit by the end of 2024, Walmart shut its health clinics in 2024, and Walgreens has not commented formally on its business status.
Healthcare stocks face 2026 policy headwinds as capex rankings highlight sector differences
Healthcare stocks were described as a defensive sector facing 2026 reimbursement headwinds, while capex rankings showed HCA Healthcare, Johnson & Johnson and Merck at the top. The sources also highlighted how capex differs across providers, device makers and drug developers.
Healthcare Investors Weigh Defensive Stocks Against Higher-Risk Growth Bets
Large-cap healthcare stocks such as Johnson & Johnson and CVS Health are viewed as defensive in a slowdown, with beta values of 0.33 and 0.46. Investors can also pursue higher-risk healthcare companies such as Grail and Viking Therapeutics, whose performance depends more on clinical and product milestones.
Healthcare Sector Leads S&P 500 as Pharma Giants Navigate 2026 Market Shift
Healthcare sector surged 10% since Q4 2025, outpacing all S&P 500 sectors as investors rotate from tech to pharmaceutical value plays. Major drugmakers demonstrate resilience following Medicare price negotiations implementation.